Log-in / Create Account  
Session Information
2008 BIO International Convention
Click here to go to the previous page
Biotechnology and Life Sciences in the EU: Current Developments in Regulations, IPR and Research Funding
Track : International Case Studies
Program Code: 1236
Date: Tuesday, June 17, 2008
Time: 10:15 AM to 11:45 AM  EST
Location: Room 26 AB
CHAIR :
Johan Vanhemelrijck, PhD, Vice President EuropaBio, EuropaBio (The European Association for Bioindustries)
SPEAKER (S):
Eduardo Fernandez-Zincke, Policy Officer, DG SANCO, European Commission
Jean-Luc Gal, Head of the Brussels Bureau, European Patent Office
Stephane Hogan, MBA, Head of Unit - Health Research , European Commission -- DG Research
Tomas Jonsson, MS, Biotechnology Policy Officer , European Commission, Enterprise and Industry DG
John Purves, PhD, Head of Sector , European Medicines Agency
Description
Highlight sources of R&D funding for collaborative research in biotechnology for health, agriculture and sustainable development.

Objective1:"Show how the EU creates opportunities for the biotechnology industry by modernizing its regulation and IPR of
biopharmaceuticals to provide legal certainty for newly emerging products."

Objective2:Present EU activities in public health and global health.

Objective3:Highlight sources of R&D funding for collaborative research in biotechnology for health, agriculture and sustainable development.

Streaming Audio with
PowerPoint Slides
(Code: 1236)
  
This session is a part of:
2008 BIO International Convention Complete Session Set
International Case Studies Track